Anti-SARS-CoV-2 equine F (Ab') 2 immunoglobulin as a possible therapy for COVID-19.

Autor: Botosso VF; Virology Laboratory, Butantan Institute, São Paulo, Brazil., Jorge SAC; Viral Biotechnology Laboratory, Butantan Institute, São Paulo, Brazil., Astray RM; Multipurpose Laboratory, Butantan Institute, São Paulo, Brazil., de Sá Guimarães AM; Microbiology Department, Biomedical Science Institute, University of São Paulo, São Paulo, Brazil., Mathor MB; Institute for Energy and Nuclear Research, São Paulo, Brazil., de Carneiro PDS; Quality Control, Butantan Institute, São Paulo, Brazil., Durigon EL; Microbiology Department, Biomedical Science Institute, University of São Paulo, São Paulo, Brazil., Covas D; Direction, Butantan Institute, São Paulo, Brazil., de Oliveira DBL; Virology Laboratory, Butantan Institute, São Paulo, Brazil.; Microbiology Department, Biomedical Science Institute, University of São Paulo, São Paulo, Brazil., das Neves Oliveira R; Bioindustrial Center, Butantan Institute, São Paulo, Brazil., Maria DA; Development and Innovation Laboratory, Butantan Institute, São Paulo, Brazil., Eto SF; Development and Innovation Laboratory, Butantan Institute, São Paulo, Brazil., Gallina NMF; Viral Vaccines Pilot Laboratory, Butantan Institute, São Paulo, Brazil., Pidde G; Immunochemistry Laboratory, Butantan Institute, São Paulo, Brazil., Squaiella-Baptistão CC; Immunochemistry Laboratory, Butantan Institute, São Paulo, Brazil., Silva DT; Center of Excellence in New Target Discovery (CENTD), Special Laboratory, São Paulo, Brazil., Villas-Boas IM; Immunochemistry Laboratory, Butantan Institute, São Paulo, Brazil., Fernandes DC; Immunochemistry Laboratory, Butantan Institute, São Paulo, Brazil., Auada AVV; Bioindustrial Center, Butantan Institute, São Paulo, Brazil., Banari AC; Microbiology Department, Biomedical Science Institute, University of São Paulo, São Paulo, Brazil., de Souza Filho AF; Microbiology Department, Biomedical Science Institute, University of São Paulo, São Paulo, Brazil., Bianconi C; Bioindustrial Center, Butantan Institute, São Paulo, Brazil., de Agostini Utescher CL; Virology Laboratory, Butantan Institute, São Paulo, Brazil., Oliveira DCA; Virology Laboratory, Butantan Institute, São Paulo, Brazil., Mariano DOC; Bioindustrial Center, Butantan Institute, São Paulo, Brazil., Barbosa FF; Multipurpose Laboratory, Butantan Institute, São Paulo, Brazil., Rondon G; Development and Innovation Laboratory, Butantan Institute, São Paulo, Brazil., Kapronezai J; Virology Laboratory, Butantan Institute, São Paulo, Brazil., da Silva JG; Quality Control, Butantan Institute, São Paulo, Brazil., Goldfeder MB; Development and Innovation Laboratory, Butantan Institute, São Paulo, Brazil., Comone P; Bioindustrial Center, Butantan Institute, São Paulo, Brazil., Junior REC; Development and Innovation Laboratory, Butantan Institute, São Paulo, Brazil., Pereira TTS; Microbiology Department, Biomedical Science Institute, University of São Paulo, São Paulo, Brazil., Wen FH; Bioindustrial Center, Butantan Institute, São Paulo, Brazil. fan.hui@butantan.gov.br., Tambourgi DV; Immunochemistry Laboratory, Butantan Institute, São Paulo, Brazil. denise.tambourgi@butantan.gov.br., Chudzinski-Tavassi AM; Development and Innovation Laboratory, Butantan Institute, São Paulo, Brazil. ana.chudzinski@butantan.gov.br.; Center of Excellence in New Target Discovery (CENTD), Special Laboratory, São Paulo, Brazil. ana.chudzinski@butantan.gov.br.

Publikováno v: Scientific reports [Sci Rep] 2022 Mar 10; Vol. 12 (1), pp. 3890. Date of Electronic Publication: 2022 Mar 10.